Cellestia

Basel, Switzerland

Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression.

Jun 2023

Non-equity Assistance

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Cellestia's investors?

Cellestia's investors include Partners Investment, Innosuisse, GoBeyond, Foundation for Innovation and Technology (FIT), EISMEA.

Where is Cellestia headquartered?

Cellestia is headquartered in Basel, Switzerland.

What does Cellestia do?

Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression.

What stage is Cellestia at?

Cellestia is at the Non-equity Assistance stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 27, 2023.

MLA

"Cellestia — Funding & Investors." VCBacked, June 27, 2023, https://www.vcbacked.co/company/cellestia. Accessed July 3, 2026.

APA

VCBacked. (2023). Cellestia — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/cellestia

Wikipedia (cite web)

{{cite web |title=Cellestia — Funding & Investors |url=https://www.vcbacked.co/company/cellestia |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 27, 2023.